| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 49 |
| 1 | ASPIRIN 325 MG | 48 |
| 2 | ASPIRIN 81 MG | 48 |
| 3 | ADALIMUMAB | 47 |
| 4 | PREDNISONE | 39 |
| 5 | OMEPRAZOLE MAGNESIUM | 37 |
| 6 | LEVOTHYROXINE SODIUM | 32 |
| 7 | FUROSEMIDE | 30 |
| 8 | IBUPROFEN | 30 |
| 9 | ALBUTEROL SULFATE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | 1 | 0.0370 |
| 1 | CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE | 1 | 0.0208 |
| 2 | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | 1 | 0.0109 |
| 3 | DIMETICONE | 1 | 0.0035 |
| 4 | PORFIMER SODIUM | 1 | 0.0029 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 8 | 0.0025 |
| 6 | DIFLUPREDNATE OPHTHALMIC | 2 | 0.0023 |
| 7 | HYDROCODONE BITARTRATE AND IBUPROFEN | 1 | 0.0021 |
| 8 | PIMOZIDE | 1 | 0.0021 |
| 9 | GAS RELIEF | 1 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 109 |
| 1 | Corticosteroid [EPC] | 83 |
| 2 | Benzodiazepine [EPC] | 59 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 57 |
| 4 | Factor Xa Inhibitor [EPC] | 39 |
| 5 | Proton Pump Inhibitor [EPC] | 36 |
| 6 | Kinase Inhibitor [EPC] | 32 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 8 | Loop Diuretic [EPC] | 30 |
| 9 | Atypical Antipsychotic [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 2 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Surfactant [EPC] | 1 | 0.0009 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 7 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 8 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |